KR100722155B1 - The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method - Google Patents

The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method Download PDF

Info

Publication number
KR100722155B1
KR100722155B1 KR1020060001422A KR20060001422A KR100722155B1 KR 100722155 B1 KR100722155 B1 KR 100722155B1 KR 1020060001422 A KR1020060001422 A KR 1020060001422A KR 20060001422 A KR20060001422 A KR 20060001422A KR 100722155 B1 KR100722155 B1 KR 100722155B1
Authority
KR
South Korea
Prior art keywords
chloromandelic acid
optically active
chloromandelic
group
acid ester
Prior art date
Application number
KR1020060001422A
Other languages
Korean (ko)
Inventor
황순욱
정선호
Original Assignee
엔자이텍 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엔자이텍 주식회사 filed Critical 엔자이텍 주식회사
Priority to KR1020060001422A priority Critical patent/KR100722155B1/en
Priority to PCT/KR2007/000085 priority patent/WO2007078176A1/en
Application granted granted Critical
Publication of KR100722155B1 publication Critical patent/KR100722155B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus
    • Y10S435/839Bacillus subtilis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/918Aspergillus oryzae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/921Candida

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

본 발명은 하기 [반응식 1]에서 일반식(1)로 표시되는 라세믹 2-클로로만델릭산 에스테르(2-chloromandelic acid ester)로부터 주요 키랄 중간체로 사용되는 일반식(2)로 표시되는 광학활성 2-클로로만델릭산 에스테르와 일반식(3)으로 표시되는 산을 제조하는 방법에 관한 것이다. 좀 더 상세하게는 수용액상 또는 용매를 포함하는 수용액상에서 반응물인 라세믹 2-클로로만델릭산 에스테르를 가수분해 효소 또는 이를 포함하는 균주를 사용하여 입체선택적으로 가수분해 반응하여 광학활성 2-클로로만델릭산 에스테르와 광학활성 2-클로로만델릭산을 제조하는 방법에 관한 것이다.The present invention provides an optical activity represented by the general formula (2) used as a chiral intermediate from the racemic 2-chloromandelic acid ester represented by the general formula (1) in the following [Scheme 1] A method for producing 2-chloromandelic acid ester and an acid represented by the general formula (3). More specifically, the reaction of the racemic 2-chloromandelic acid ester, which is a reactant in an aqueous solution or an aqueous solution containing a solvent, by stereoselective hydrolysis using a hydrolase or a strain comprising the optically active 2-chloroman The present invention relates to a process for preparing a delic acid ester and an optically active 2-chloromandelic acid.

본 발명은 위에서 언급한 광학활성 2-클로로만델릭산 에스테르 및 산의 제조에 있어서 새로운 방법을 제시하며, 광학순도가 높고 생성물의 제조 및 분리가 용이하여 실제 공정에 유용한 것으로 판단된다.The present invention presents a novel method for the preparation of the above-mentioned optically active 2-chloromandelic acid esters and acids, and is believed to be useful for the actual process due to its high optical purity and ease of preparation and separation of the product.

[반응식1][Scheme 1]

Figure 112006000818715-pat00001
Figure 112006000818715-pat00001

(상기 화합물의 치환체 R은 치환되거나 또는 치환되지 않은 탄소수 1 내지 8의 알킬기 또는 알케닐기, 벤질기, 탄소수 3 내지 6의 싸이클로알킬기, 치환되거나 치환되지 않은 아릴알킬기, 및 치환되거나 치환되지 않은 헤테로아릴알킬기로 이루 어진 군으로부터 선택되어진다.)(Substituent R of the compound is substituted or unsubstituted alkyl group or alkenyl group having 1 to 8 carbon atoms, benzyl group, cycloalkyl group having 3 to 6 carbon atoms, substituted or unsubstituted arylalkyl group, and substituted or unsubstituted heteroaryl It is selected from the group consisting of alkyl groups.)

2-클로로만델릭산, 리파제, 광학활성, 가수분해 반응, 클로피도그렐 2-chloromandelic acid, lipase, optical activity, hydrolysis reaction, clopidogrel

Description

효소적 방법에 의한 광학활성 2-클로로만델릭산 에스테르와 2-클로로만델릭산의 제조 방법{The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method}The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method}

본 발명은 효소 또는 미생물에 의한 광학활성 2-클로로만델릭산 에스테르와 이의 산의 제조방법에 관한 것이다. 좀 더 상세하게는 가수분해 효소 또는 가수분해 효소 생산능을 갖는 미생물을 이용하여 [반응식 1]에서 일반식(1)로 표시되는 라세믹 2-클로로만델릭산 에스테르를 일반식(2)로 표시되는 광학활성 2-클로로만델릭산 에스테르와 일반식(3)으로 표시되는 2-클로로만델릭산으로 가수분해 하는 방법에 관한 것이다.The present invention relates to an optically active 2-chloromandelic acid ester by an enzyme or a microorganism and a method for preparing an acid thereof. More specifically, the racemic 2-chloromandelic acid ester represented by the general formula (1) in [Scheme 1] using a microorganism having a hydrolase or a hydrolase production capacity is represented by the general formula (2). The present invention relates to a method of hydrolyzing an optically active 2-chloromandelic acid ester and 2-chloromandelic acid represented by the general formula (3).

Figure 112006000818715-pat00002
Figure 112006000818715-pat00002

(상기 화합물의 치환체 R은 치환되거나 또는 치환되지 않은 탄소수 1 내지 8의 알킬기 또는 알케닐기, 벤질기, 탄소수 3 내지 6의 싸이클로알킬기, 치환되거나 치환되지 않은 아릴알킬기, 및 치환되거나 치환되지 않은 헤테로아릴알킬기로 이루어진 군으로부터 선택되어진다.)(Substituent R of the compound is substituted or unsubstituted alkyl group or alkenyl group having 1 to 8 carbon atoms, benzyl group, cycloalkyl group having 3 to 6 carbon atoms, substituted or unsubstituted arylalkyl group, and substituted or unsubstituted heteroaryl Is selected from the group consisting of alkyl groups.)

상기에서 언급한 광학활성 2-클로로만델릭산 에스테르는 주요 혈전용해제인 클로피도그렐 바이설파이트((S)-Clopidogrel bisulfate)의 합성에 필요한 키랄 중간체로서 활용범위가 넓다. 토실화 또는 메실화 된 화합물을 무기염 조건하에서 에폭시화하여 다양한 분야의 신약에 적용되는 중요한 의약중간체인 광학활성 2-클로로스틸렌 옥사이드(2-chlorostyrene oxide)로의 전환이 가능하다(대한민국 공개특허 10-2005-0035057). The above-mentioned optically active 2-chloromandelic acid ester is widely used as a chiral intermediate required for the synthesis of clopidogrel bisulfate ((S) -Clopidogrel bisulfate). The tosylated or mesylated compounds can be epoxidized under inorganic salt conditions to be converted into optically active 2-chlorostyrene oxide, which is an important pharmaceutical intermediate applied to new drugs in various fields (Republic of Korea). 2005-0035057).

Noda Hirobumi 등(일본특허 0072644)은 분할제(resolution agent)로 광학활성 N-벤질-2-페닐에틸아민(N-benzyl-1-phenylbutylamine)을 이용하여 라세믹 2-클로로만델릭산으로부터 부분입체이성질체 염(diastereomer salt)를 만들고 산성화하여 (R)-2-클로로만델릭산을 얻었다. 이 공정은 재결정 과정을 필요로 하는 단점이 있다. 비슷한 방법으로 Hyoda Toshiharu 등(일본특허 0114737)은 분할제로 광학활성 알라닌(alanine)을 사용하여 상기 물질을 얻은 바 있다. Noda Hirobumi et al. (Japanese Patent No. 0072644) use diastereomers from racemic 2-chloromandelic acid using optically active N-benzyl-1-phenylbutylamine as a resolution agent. Isomer salts were prepared and acidified to afford (R) -2-chloromandelic acid. This process has the disadvantage of requiring a recrystallization process. In a similar manner, Hyoda Toshiharu et al. (Japanese Patent 0114737) have obtained the material using optically active alanine as a splitting agent.

North michael 등(국제공개특허 00210095)은 키랄 리간드와 키랄 촉매를 사용하여 2-클로로벤즈알데하이드의 시안산화(cyanation)와 아세틸화(acetylation) 과정을 거쳐 (R)-O-아세틸-시아노히드린을 얻고 가수분해하여 (R)-2-클로로만델릭산을 얻었다. 본 방법은 반응을 수행하는 조건이 까다롭고 재결정과정을 여러번 수행해야 한다. North michael et al. (International Patent No. 00210095) use a chiral ligand and a chiral catalyst to undergo cyanation and acetylation of 2-chlorobenzaldehyde to obtain (R) -O -acetyl-cyanohydrin. Obtained and hydrolyzed to obtain (R) -2-chloromandelic acid. This method is difficult to carry out the reaction and requires several recrystallization processes.

한편 효소 및 균주를 이용하는 방법으로는 다음과 같은 방법들이 있다.On the other hand, there are the following methods using the enzyme and strain.

김종근 등(대한민국 공개특허 10-2004-0063264)은 효모(Baker´s yeast)를 이용하여 (R)-2-클로로만델릭산 및 그 에스테르 유도체를 제조하였다. 2-클로로만델릭산으로부터 2-클로로만델레이트 알킬 에스테르 화합물을 제조하고 다시 알킬 2-클로로-벤조일포메이트(Alkyl 2-chloro-benzoylformate)로 합성한 다음, 효모를 이용하여 비대칭 환원 반응(asymmetric reduction)하였다. 메틸 2-클로로-벤조일포메이트, 에틸 2-클로로-벤조일포메이트, 부틸 2-클로로-벤조일포메이트의 경우 4시간 반응 후 각각 전환율 99.9 %, 88.5 %, 99.7% 이었으며 광학순도는 각각 98.45 ee%, 98.5 ee%, 98.4 ee% 의 결과를 보였다. 이 공정은 효모를 이용한 반응 전에 여러번의 합성 단계를 거치는 단점이 있다.Kim, Jong-Keun et al. (Korean Patent Laid-Open Publication No. 10-2004-0063264) prepared (R) -2-chloromandelic acid and ester derivatives thereof by using yeast (Baker's yeast). A 2-chloromandelate alkyl ester compound was prepared from 2-chloromandelic acid and synthesized again with alkyl 2-chloro-benzoylformate, followed by asymmetric reduction using yeast. reduction). In the case of methyl 2-chloro-benzoylformate, ethyl 2-chloro-benzoylformate, and butyl 2-chloro-benzoylformate, the conversion was 99.9%, 88.5%, and 99.7% after 4 hours, respectively, and the optical purity was 98.45 ee%, respectively. , 98.5 ee%, 98.4 ee%. This process has the disadvantage of undergoing several synthetic steps before the reaction with yeast.

엄기남 등(대한민국 공개특허 10-2005-0035057)은 2-클로로만델릭산 에스테르를 제조한 후 유기 용매 상에서 가수 분해 효소를 이용하여 에스테르 반응에 의해 (R)-2-클로로만델릭산 에스테르(100 ee%)와 (S)-2-클로로만델릭 디에스테르로 광학분할 하였다. 하지만 이 공정은 반응 후 각 생성물의 분리가 쉽지 않은 단점을 갖는다.Eom, Ki-Nam et al. (Republic of Korea Patent Publication No. 10-2005-0035057) prepared 2-chloromandelic acid ester and then (R) -2-chloromandelic acid ester (B) by ester reaction using a hydrolytic enzyme in an organic solvent. 100 ee%) and (S) -2-chloromandelic diester were optically divided. However, this process has a disadvantage in that it is not easy to separate each product after the reaction.

Van Langen 등(Organic Process Research & Development, 2003, 7, 828-831)은 2-클로로벤즈알데히드(2-chlorobenzaldehyde)로부터 옥시니트릴라제(oxynitrilase)를 사용하여 2-(2-클로로페닐)-2-히드록시아세토나이트릴(2-(2-chlorophenyl)2-hydroxyacetonitrile)을 제조하고, 다시 산 조건에서 가수분해하고 재결정하여 광학순도 99 ee%의 (R)-2-클로로만델릭산을 제조하였다.Van Langen et al. (Organic Process Research & Development, 2003, 7, 828-831) use 2- (2-chlorophenyl) -2- using oxynitrilase from 2-chlorobenzaldehyde. Hydroxyacetonitrile (2- (2-chlorophenyl) 2-hydroxyacetonitrile) was prepared, and hydrolyzed and recrystallized under acidic conditions to prepare (R) -2-chloromandelic acid having an optical purity of 99 ee%.

이에 본 발명자들은 기존의 보고된 제조 방법 대신에 반응이 간단하며, 생성물의 회수가 쉬운 공정을 개발하고자 하였다. 본 발명에 의한 제조 방법은 가수 분해 효소 또는 이를 포함하는 균주를 이용하여 라세믹 2-클로로만델릭산 에스테르를 가수분해 반응하여 광학활성 2-클로로만델릭산 에스테르와 광학활성 2-클로로만델릭산을 제조하는 방법으로 현재까지 보고된 바가 없는 새로운 공정이다. 또한 본 발명에 의해 제조되는 2-클로로만델릭산 에스테르 및 그의 산은 분리 및 회수가 쉽기 때문에 실제 공정에 유리하게 이용될 수 있다. Thus, the present inventors have attempted to develop a process in which the reaction is simple and the product is easy to recover instead of the previously reported manufacturing method. The production method according to the present invention hydrolyzes racemic 2-chloromandelic acid esters using a hydrolase or a strain comprising the same, thereby optically active 2-chloromandelic acid esters and optically active 2-chloromandelic acid It is a new process that has not been reported so far as a method for preparing. In addition, 2-chloromandelic acid esters and acids thereof prepared according to the present invention can be advantageously used in practical processes because they are easy to separate and recover.

이하 본 발명을 좀 더 구체적으로 살펴보면 다음과 같다. 전술한 바와 같이 본 발명은 라세믹 2-클로로만델릭산 에스테르로부터 가수분해 효소 또는 이를 포함하는 균주를 이용하여 입체선택적으로 가수분해하여 광학활성 2-클로로만델릭산 에스테르와 광학활성 2-클로로만델릭산을 제조하는 방법에 대한 것이다. 또한 반응을 통해 얻어진 광학활성 2-클로로만델릭산 에스테르는 수산화나트륨(NaOH) 등을 사용하여 가수분해하면 광학활성 2-클로로만델릭산으로 전환할 수 있다. Looking at the present invention in more detail as follows. As described above, the present invention is stereoselectively hydrolyzed by using a hydrolase or a strain comprising the same from racemic 2-chloromandelic acid ester, thereby optically active 2-chloromandelic acid ester and optically active 2-chloroman. To a process for preparing delic acid. In addition, the optically active 2-chloromandelic acid obtained through the reaction can be converted to the optically active 2-chloromandelic acid by hydrolysis using sodium hydroxide (NaOH) and the like.

본 발명에 사용되는 효소는 CAL A(노보자임 735),고정화 리파제 CAL B(노보자임 435, Novozyme 사)와 알칼라제(Alcalase), 프로티아제 A(Protease A) 또는 이들 가수분해 효소를 포함하는 균주가 있으나 이에 한정되는 것은 아니다.Enzymes used in the present invention include CAL A (novozyme 735), immobilized lipase CAL B (Novozyme 435, Novozyme) and alcalase, Protease A or these hydrolytic enzymes. There is a strain that is not limited thereto.

본 발명에 있어서, 반응에 사용되는 반응물 및 생성물들은 다음과 같은 조건에서 분석하였다.In the present invention, the reactants and products used in the reaction were analyzed under the following conditions.

라세믹 2-클로로만델릭산 에스테르는 모세관 컬럼인 HP-FFAP(Agilent사)가 장착된 기체크로마토그래피(도남인스트루먼트사, 모델 DS6200)를 이용하여 분석하였다. 100 ℃에서 5 분간 가열 후 220 ℃ 까지 분당 20 ℃씩 올려주고, 220 ℃에서 10 분 동안 유지하였으며, 담체로는 헬륨기체를 사용하였고 컬럼 헤드 압력을 6 psi로 유지하면서 220 ℃에서 FID를 사용하여 검출하였다. 상기 조건에서 메틸 2-클로로만델레이트는 15.31 분, 에틸 2-클로로만델레이트는 14.89 분, 부틸 2-클로로만델레이트는 17.28 분에서 각각 검출되었다.The racemic 2-chloromandelic acid esters were analyzed using gas chromatography (Donan Instruments, Model DS6200) equipped with a capillary column HP-FFAP (Agilent). After heating at 100 ° C. for 5 minutes, the temperature was raised to 220 ° C. by 20 ° C. per minute, and maintained at 220 ° C. for 10 minutes. Helium gas was used as the carrier, and the column head pressure was maintained at 6 psi. Detected. Under these conditions, methyl 2-chloromandelate was detected at 15.31 minutes, ethyl 2-chloromandelate at 14.89 minutes and butyl 2-chloromandelate at 17.28 minutes, respectively.

광학활성 2-클로로만델릭산 에스테르는 키랄 컬럼 AD-H(Daicel 사)가 장착된 HPLC(Lab Aliance사, 모델 201)을 사용하여 분석하였다. 헥산과 이소프로파놀을 90:10의 비율로 혼합하여 분당 0.7 ml로 흘려주었고, UV 흡광도는 220 nm로하여 분석하였다. 이 때 (S)와 (R)-메틸 2-클로로만델레이트는 각각 12.71 분과 13.93 분에서 검출되었고, (S)와 (R)-에틸 2-클로로만델레이트는 각각 12.00 분과 13.95 분에서 검출되었으며, (S)와 (R)-부틸 2-클로로만델레이트는 10.36 분과 12.06 분에서 각각 검출되었다.Optically active 2-chloromandelic acid esters were analyzed using HPLC (Lab Aliance, Model 201) equipped with chiral column AD-H (Daicel). Hexane and isopropanol were mixed at a ratio of 90:10 and flowed at 0.7 ml per minute, and the UV absorbance was analyzed at 220 nm. At this time, (S) and (R) -methyl 2-chloromandelate were detected at 12.71 and 13.93 minutes, respectively, and (S) and (R) -ethyl 2-chloromandelate were detected at 12.00 and 13.95 minutes, respectively. (S) and (R) -butyl 2-chloromandelate were detected at 10.36 and 12.06 minutes, respectively.

이하 실시예를 통하여 본 발명을 좀 더 구체적으로 설명하지만, 하기 예에 본 발명의 범주가 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the scope of the present invention is not limited to the following Examples.

실시예 1. 라세믹 알킬 2-클로로만델레이트의 제조Example 1 Preparation of Racemic Alkyl 2-chloromandelate

메탄올 40 ml에 라세믹 2-클로로만델릭산 2 g을 넣고 35 % 염산 용액을 첨가하여 75 ℃에서 3 시간 반응하였다. 생성물은 중화 후 유기층으로 추출한 뒤 감압 증류를 통해 용매를 제거하여 얻었다. 라세믹 에틸 2-클로로만델레이트와 부틸 2-클로로만델레이트는 메탄올 대신에 에탄올과 부탄올을 각각 사용하여 상기의 조건에서 반응 후 제조하였다. 이에 따라 제조된 생성물은 실리카겔 상에서 정제하고 라세믹 2-클로로만델릭산 에스테르임을 핵자기공명(Burker사, 모델 DRX300)으로 확인하였으며 분석결과는 다음과 같다.2 g of racemic 2-chloromandelic acid was added to 40 ml of methanol, and a 35% hydrochloric acid solution was added thereto and reacted at 75 ° C. for 3 hours. The product was neutralized and extracted with an organic layer, followed by removal of the solvent through distillation under reduced pressure. Racemic ethyl 2-chloromandelate and butyl 2-chloromandelate were prepared after the reaction under the above conditions using ethanol and butanol instead of methanol, respectively. The product thus prepared was purified on silica gel and confirmed to be racemic 2-chloromandelic acid ester by nuclear magnetic resonance (Burker, model DRX300). The analysis results are as follows.

메틸 2-클로로만델레이트Methyl 2-chloromandelate

1H-NMR(CDCl3, 300MHz) δ(ppm)= 3.76(s,3H), 5.57(s,1H), 7.27(m,2H), 7.39(m,2H) 1 H-NMR (CDCl 3 , 300 MHz) δ (ppm) = 3.76 (s, 3H), 5.57 (s, 1H), 7.27 (m, 2H), 7.39 (m, 2H)

에틸 2-클로로만델레이트Ethyl 2-chloromandelate

1H-NMR(CDCl3, 300MHz) δ(ppm)=1.21(t,3H), 4.21(m,2H), 5.54(s,1H), 7.27(m,2H), 7.38(m,2H) 1 H-NMR (CDCl 3 , 300 MHz) δ (ppm) = 1.21 (t, 3H), 4.21 (m, 2H), 5.54 (s, 1H), 7.27 (m, 2H), 7.38 (m, 2H)

부틸 2-클로로만델레이트Butyl 2-chloromandelate

1H-NMR(CDCl3, 300MHz) δ(ppm)=0.83(t,3H), 1.23(m,2H), 1.54(m,2H), 4.16(t,2H), 5.56(s,1H), 7.25(m,2H),7.38(m,2H) 1 H-NMR (CDCl 3 , 300 MHz) δ (ppm) = 0.83 (t, 3H), 1.23 (m, 2H), 1.54 (m, 2H), 4.16 (t, 2H), 5.56 (s, 1H), 7.25 (m, 2H), 7.38 (m, 2H)

실시예 2-3. 가수분해 반응을 통한 광학활성 메틸 2-클로로만델레이트의 제조Example 2-3. Preparation of Optically Active Methyl 2-chloromandelate Through Hydrolysis

0.1 M 인산 완충용액(potassium phosphate buffer, pH 7.0) 5 ml 이 들어있는 바이알에 실시예 1의 방법으로 생성된 라세믹 메틸 2-클로로만델레이트를 1 %(w/v)가 되도록 첨가하고 표 1에 기재된 효소 1 %(w/v)를 사용하여 30 ℃에서 반응을 수행하였다. 일정시간 반응 후 아세트산 에틸로 추출하여 생성물을 상기 분석방법에 따라 분석하였고 그 결과를 표1에 나타내었다.To a vial containing 5 ml of 0.1 M potassium phosphate buffer (pH 7.0), add racemic methyl 2-chloromandelate produced by the method of Example 1 to 1% (w / v) and The reaction was carried out at 30 ° C. using 1% (w / v) of the enzyme described in 1. After a certain reaction, the product was extracted with ethyl acetate and analyzed according to the above analysis method. The results are shown in Table 1.

실시예Example 효소종류Enzyme Type 반응시간(hr)Response time (hr) 전환율(%)% Conversion 광학활성 메틸 2-클로로만델레이트(ee%)Optically active methyl 2-chloromandelate (ee%) 형태shape 22 CAL ACAL A 6767 94.594.5 >99> 99 RR 33 CAL BCAL B 6767 79.579.5 95.995.9 RR

실시예 4-7. 가수분해 반응을 통한 광학활성 에틸 2-클로로만델레이트의 제조Example 4-7. Preparation of optically active ethyl 2-chloromandelate via hydrolysis reaction

실시예 2에서 반응물로 사용된 메틸 2-클로로만델레이트 대신에 에틸 2-클로로만델레이트를 사용하여 표 2에 기재된 효소를 이용하여 반응하고 그 결과는 다음과 같다.Instead of methyl 2-chloromandelate used as a reactant in Example 2 using ethyl 2-chloromandelate using the enzymes listed in Table 2 and the results are as follows.

실시예Example 효소종류Enzyme Type 반응시간(hr)Response time (hr) 전환율(%)% Conversion 광학활성 에틸 2-클로로만델레이트(ee%)Optically active ethyl 2-chloromandelate (ee%) 형태 shape 44 Alcalase 2.5LAlcalase 2.5L 8787 79.279.2 93.493.4 SS 55 CAL ACAL A 4646 89.389.3 99.399.3 RR 66 CAL BCAL B 2222 63.463.4 99.899.8 RR 77 Protease AProtease A 8787 92.492.4 9999 SS

실시예 8. 가수분해 반응을 통한 광학활성 부틸 2-클로로만델레이트의 제조Example 8. Preparation of Optically Active Butyl 2-Chloromandelate Through Hydrolysis Reaction

실시예 2에서 반응물로 사용된 메틸 2-클로로만델레이트 대신에 부틸 2-클로로만델레이트를 사용하고 CAL B로 48 시간 반응하여 전환율 93.1 % 일 때, 광학순도 76.0 ee%를 갖는 부틸 (R)-클로로만델레이트를 제조하였다.Butyl (R) having an optical purity of 76.0 ee% when the conversion rate was 93.1% using butyl 2-chloromandelate instead of methyl 2-chloromandelate used as a reactant in Example 2 and reacting with CAL B for 48 hours. ) -Chloromandelate was prepared.

실시예 9. 광학활성 (R)-2-클로로만델릭산의 제조Example 9 Preparation of Optically Active (R) -2-chloromandelic Acid

라세믹 에틸 2-클로로만델레이트를 실시예 6에서 사용된 CAL B를 사용하여 가수분해 반응에 의해 광학순도 99 ee%의 에틸 (R)-2-클로로만델레이트로 얻었다. 회수한 에틸 (R)-2-클로로만델레이트를 메탄올에 녹이고 10 %(w/v) 수산화나트륨 용액을 첨가한 후 상온에서 충분히 반응한 후, 반응액을 염산 용액을 이용하여 pH 1로 조절하고 t-부틸 메틸에스테르(t-BME)를 사용하여 생성물로 흰색 고체를 수득하였다. 분석결과 광학순도 99 ee%의 (R)-2-클로로만델릭산임을 확인하였다. Racemic ethyl 2-chloromandelate was obtained by hydrolysis reaction with CAL B used in Example 6 as ethyl (R) -2-chloromandelate of optical purity 99 ee%. The collected ethyl (R) -2-chloromandelate was dissolved in methanol, 10% (w / v) sodium hydroxide solution was added, and then sufficiently reacted at room temperature. The reaction solution was then adjusted to pH 1 using hydrochloric acid solution. And t-butyl methyl ester (t-BME) to give a white solid as a product. The analysis results confirmed that the optical purity was 99 ee% (R) -2-chloromandelic acid.

상기 실시예 2-9을 통해 알 수 있는 것과 같이, 광학활성 2-클로로만델릭산 에스테르를 제조하는 방법에 있어서 본 발명에 따른 가수분해 반응은 반응이 용이하고, 높은 광학순도의 생성물을 얻을 수 있다. 또한 반응 후 각각의 광학활성 에스테르와 2-클로로만델릭산의 회수가 용이하여 산업적으로 대량생산에 적절한 제조 공정이다. As can be seen through Example 2-9, in the method for preparing the optically active 2-chloromandelic acid ester, the hydrolysis reaction according to the present invention is easy to react, it is possible to obtain a product of high optical purity have. In addition, it is easy to recover each optically active ester and 2-chloromandelic acid after the reaction is a suitable manufacturing process for industrial mass production.

Claims (2)

하기 [반응식 1]에서 일반식(1)로 표시되는 라세믹 2-클로로만델릭산 에스테르를 캔디다 앤타르크티카(Candida antarctica), 바실러스 서브틸리스(Bacillus subtilis) 또는 아스퍼질러스 오라이제(Aspergillus oryzae)로부터 선택되는 미생물 유래의 리파제, 또는 캔디다 앤타르크티카, 바실러스 서브틸리스 또는 아스퍼질러스 오라이제로부터 선택되는 리파제 생성능을 갖는 미생물을 이용하여 가수분해시키는 것을 특징으로 하는 일반식(2)로 표시되는 광학활성 2-클로로만델릭산 에스테르와 일반식(3)으로 표시되는 광학활성 2-클로로만델릭산의 제조 방법.The racemic 2-chloromandelic acid ester represented by the general formula (1) in the following [Scheme 1] is Candida antarctica , Bacillus subtilis or Aspergillus orisase ( Aspergillus oryzae). Lipase derived from a microorganism selected from C.) or a microorganism having a lipase-generating ability selected from Candida antarctica, Bacillus subtilis, or Aspergillus orisase, represented by the general formula (2). Method for producing an optically active 2-chloromandelic acid ester and the optically active 2-chloromandelic acid represented by the general formula (3). [반응식 1] Scheme 1
Figure 712007001314400-pat00004
Figure 712007001314400-pat00004
(상기 화합물의 치환체 R은 치환되거나 또는 치환되지 않은 탄소수 1 내지 8의 알킬기 또는 알케닐기, 벤질기, 탄소수 3 내지 6의 싸이클로알킬기, 치환되거나 치환되지 않은 아릴알킬기, 및 치환되거나 치환되지 않은 헤테로아릴알킬기로 이루어진 군으로부터 선택되어진다.)(Substituent R of the compound is substituted or unsubstituted alkyl group or alkenyl group having 1 to 8 carbon atoms, benzyl group, cycloalkyl group having 3 to 6 carbon atoms, substituted or unsubstituted arylalkyl group, and substituted or unsubstituted heteroaryl Is selected from the group consisting of alkyl groups.)
삭제delete
KR1020060001422A 2006-01-05 2006-01-05 The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method KR100722155B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020060001422A KR100722155B1 (en) 2006-01-05 2006-01-05 The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method
PCT/KR2007/000085 WO2007078176A1 (en) 2006-01-05 2007-01-05 The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060001422A KR100722155B1 (en) 2006-01-05 2006-01-05 The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method

Publications (1)

Publication Number Publication Date
KR100722155B1 true KR100722155B1 (en) 2007-05-28

Family

ID=38228460

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060001422A KR100722155B1 (en) 2006-01-05 2006-01-05 The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method

Country Status (2)

Country Link
KR (1) KR100722155B1 (en)
WO (1) WO2007078176A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102206686B (en) * 2011-04-19 2013-06-26 华东理工大学 Preparation method of methyl (R)-o-chloromandelate utilizing biocatalytic asymmetric reduction
CN108192932B (en) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 Enzyme catalysis preparation method of chiral alcohol
CN111118073B (en) * 2019-12-27 2022-02-15 宜昌东阳光生化制药有限公司 Method for synthesizing intermediate of ezetimivir by enzyme method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001072644A (en) 1999-09-06 2001-03-21 Yamakawa Yakuhin Kogyo Kk Production of optically active 2-chloromandelic acid and production intermediate
JP2002114737A (en) 2000-10-11 2002-04-16 Japan Hydrazine Co Inc METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID
EP1382674A2 (en) 2002-07-16 2004-01-21 Daicel Chemical Industries, Ltd. Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same
KR20040063264A (en) * 2003-01-06 2004-07-14 에스케이 주식회사 Method for preparing optically active (R)-2-chloromandelic acid and its ester derivatives using Baker's Yeast
KR20050035057A (en) * 2003-10-11 2005-04-15 주식회사 아이디알 Process for (r) or (s)-2-chlorostyrene oxide by using enzyme

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2720140B2 (en) * 1993-02-03 1998-02-25 日東化学工業株式会社 Method for producing optically active α-hydroxycarboxylic acid having phenyl group

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001072644A (en) 1999-09-06 2001-03-21 Yamakawa Yakuhin Kogyo Kk Production of optically active 2-chloromandelic acid and production intermediate
JP2002114737A (en) 2000-10-11 2002-04-16 Japan Hydrazine Co Inc METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID
EP1382674A2 (en) 2002-07-16 2004-01-21 Daicel Chemical Industries, Ltd. Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same
KR20040063264A (en) * 2003-01-06 2004-07-14 에스케이 주식회사 Method for preparing optically active (R)-2-chloromandelic acid and its ester derivatives using Baker's Yeast
KR20050035057A (en) * 2003-10-11 2005-04-15 주식회사 아이디알 Process for (r) or (s)-2-chlorostyrene oxide by using enzyme

Also Published As

Publication number Publication date
WO2007078176A1 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
JPS63273499A (en) Production of optically active compound
KR100722155B1 (en) The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method
KR100846676B1 (en) The method of making optically active 2-halo-2-n-substituted phenylacetic acid esters and 2-halo-2-n-substituted phenylacetic acids by enzymatic method
EP1290209B1 (en) Method for preparing an r- or s-form of alpha-substituted heterocyclic carboxylic acid and a counter enantiomeric form of alpha-substituted heterocyclic carboxylic acid ester thereto using enzyme
KR100758512B1 (en) The method of preparing optically active 3-hydroxy-3-phenylpropionic acids and optically active 3-acyloxy-3-phenylpropionic acid by enzymatic method
EP1290208B1 (en) Method for optically resolving a racemic alpha-substituted heterocyclic carboxylic acid using enzyme
EP0512848A2 (en) Enzymatic resolution of alpha-tertiary carboxylic acid esters
KR100657204B1 (en) The method of making optically active 3-hydroxy-?-butyrolactone by enzymatic method
CA2145230A1 (en) Enzymatic resolution of asymmetric alcohols by means of vinyl esters of polybasic carboxylic acids
KR100368735B1 (en) Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme
KR100973710B1 (en) The method for preparing optically active n-substituted phenylglycine alkyl esters by enzymatic method
KR100395310B1 (en) Method for optically resolving preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme
KR100650798B1 (en) Process for preparing chiral substituted carboxylic acid
KR100846674B1 (en) The method of preparing optically active trans-alcohols and their esters by enzymatic method
JP2007117034A (en) Method for producing optically active nipecotic acid compound
JP3583798B2 (en) Method for producing optically active 2-methylbutanoic acid and derivatives thereof
KR100651393B1 (en) Mothod for preparing R-1-amino-2-propanol using hydrolysis enzyme
WO2007035066A1 (en) The method of making optically active 3-acyloxy-gamma-butyrolactone and optically active 3-hydroxy-gamma-butyrolactone by enzymatic method
JP2609922B2 (en) 2'-Ketopantothenic acid ester
KR100748897B1 (en) The method of making optically active 3-hydroxybutyric acid and their esters by enzymatic method
JP2008271827A (en) METHOD FOR PRODUCING OPTICALLY ACTIVE N-ARYL-beta-AMINO ACID COMPOUND
KR20100116727A (en) A method for preparing opically active alcoholic compounds derivatives
JPH10248592A (en) Production of optically active 2-benzylsuccinic acid and its derivative
KR20040071452A (en) The method of making optically active ethyl 3-hydroxy-3-phenylpropionate and their esters by enzymatic method
JP2009263341A (en) Method of manufacturing optically active nipecotic acid ester derivative

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121121

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20130618

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee